Virtual Care: A New Era in Neurology

By Staff Writer

September 6, 2023

As the world grapples with an ageing population and increasing prevalence of chronic diseases, the demand for continuous home and institutional care is expected to rise significantly. This growing need, coupled with the ongoing COVID-19 pandemic, has led to a major advance in the use of virtual care tools. These tools have been instrumental in ensuring access to care and services, promoting continuity of care, and are now being integrated into care pathways for the evaluation, treatment, and follow-up of patients in specialty medicine, particularly neurology.

The Ministère de la Santé et des Services sociaux (MSSS) has initiated a national project on virtual care, mandating the Institut national d’excellence en santé et en services sociaux (INESSS) to provide a state-of-knowledge report to guide the use of virtual care in specialty medicine. This initiative aims to inform public decision-makers, medical associations, and health and social services professionals about virtual care practices in specialty medicine.

The project comprises seven reports, one of which focuses on neurology. The report presents a scoping review of the care pathways that can be supported or optimised with the use of virtual care. The review encompassed scientific and grey literature from the past five years, existing national and international guidelines, guidance and discussion papers, and health technology assessment (HTA) reports.

The findings from the review suggest that telerehabilitation is the most studied intervention across all care pathways. The review also highlights the need for additional good-quality studies to further validate the effectiveness of virtual care interventions.

The report also outlines several care pathways in neurology that have been reported as being clinically effective through the use of virtual care. These include identifying and diagnosing mild and major neurocognitive disorders via teleconsultation, improving cognitive functions through telerehabilitation via videoconferencing, and improving motor functions through physical telerehabilitation via videoconferencing among others.

Despite the promising results, the report also acknowledges the limitations of the study and the need for further research to clarify certain aspects of virtual care. Nevertheless, the findings provide valuable insights into the potential of virtual care in transforming the field of neurology and healthcare as a whole.

As the world continues to navigate through the challenges of the pandemic, the integration of virtual care in healthcare systems worldwide is more important than ever. It is hoped that with continued research and advancements in technology, virtual care will continue to improve access to healthcare and foster patient engagement in managing their illnesses. 

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.